REFERENCES
- Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Eng J Med 1992; 326:927–932.
- Redman CWG. The Placenta, preeclampsia and chronic villitis. In: Redman CWG, Sargent IL, Starkey PM, eds. The Human Placenta, London, England: Blackwell Scientific Publications; 1993:433–467.
- Hayman R, Brockelsby J, Kenny L, Baker P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Invest 1999; 6:3–10.
- Roberts J. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16:5–15.
- Roberts JM. Pregnancy related hypertension. In: Creasy RK, Resnik R, eds. Maternal Fetal Medicine: Principles and Practise, Philadelphia: W.B. Saunders, 1989.
- Mohaupt M. Molecular aspects of preeclampsia. Mol Aspects Med 2007; 28:169–191.
- Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 2000; 4:441–448.
- Kitamura K, Kangawa K, Kawamoto M, Ichiki Y. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192:553–560.
- Jerat S, Morrish DW, Davidge ST, Kaufman S. Effect of adrenomedullin on placental arteries in normal and preeclamptic pregnancies. Hypertension 2001; 37:227–231.
- National High Blood Pressure Education Program Working on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:1–22.
- Wilcox MA, Jhonson IR, Maynard PV, Smith SJ, Chilvers CED. The individualized birthweight ratio: a more logical outcome measure of pregnancy than birthweight alone. Br J Obstet Gynaecol 1993; 100:342–347.
- Buege JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978; 52:302–310.
- Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357:53–56.
- Kauma S, Takacs P, Scordalakes C, Walsh S. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol 2002; 100:706–714.
- Serdar Z, Gur E, Develioglu O, Colakogullari M. Placental and desidual lipid peroxidation and antioxidant defenses in preeclampsia lipid peroxidation in preecclampsia. Pathophysiology 2002; 9:21–25.
- Kumar CA, Das UN. Lipid peroxides, antioxidants and nitric oxide in patients with preeclampsia and essential hypertension. Med Sci Monit 2000; 6:901–907.
- Sikkema JM, Van Rijn BB, Franx A, . Placental superoxide is increased in preeclampsia. Placenta 2001; 22:304–308.
- Vane JR, Botting RM. Regulatory functions of the vascular endothelium. N Eng J Med 1990; 323:27–36.
- Vane JR, Botting RM. The role of chemical mediators released by the endothelium in the control of the cardiovascular system. Int J Tissue React 1992; 14:55–64.
- Inoue M, Nishikawa M, Sato EE. Cross talk of NO, superoxide and molecular oxygen, a majesty of aerobic life. Free Rad Res 1999; 31:251–261.
- Vatish M, Harpal SR, Grammatopoulos KD. Hormonal regulation of placental nitric oxide and pathogenesis of preeclampsia. Trends Mol Med 2006; 12:223–233.
- Kilicdag EB, Ay G, Çelik A, Ustundag B. Oxidant–antioxidant system changes relative to placental-umbilical pathology in patients with preeclampsia. Hypertens Preg 2005; 24:147–157.
- Jaugasaki M, Wei CM, Aarhus LL. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 1995; 268:657–663.
- Parkes DG. Cardivascular actions of adrenomedullin in conscious sheep. Am J Physiol 1995; 268:2574–2578.
- Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol 1995; 289:383–385.
- Jerat S, Donald WM, Davidge ST, Kaufman S. Effect of adrenomedullin on placental arteries in normal and preeclamptic pregnancies. Hypertension 2001; 37:227–231.